Search Results 51-60 of 16799 for Selective estrogen receptor modulator

  1. Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    Triple negative means that the breast cancer does not express other hormone receptors called ER alpha, progesterone, and HER2. In some people with triple ...

  2. Conjugated estrogens synthetic b (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to treat moderate to severe changes in and around the vagina (eg, vaginal dryness, itching, and burning) caused by menopause. This medicine is ...

  3. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    Prior therapy with any BET inhibitor, any selective estrogen receptor degrader (SERD) including fulvestrant, or inhibitors of the PI3K/AKT/mTOR pathway.

  4. Mayo Clinic Q and A: Treatment for vaginal dryness for menopausal women

    As a woman ages, her body makes less of the hormone estrogen. In ... An oral medication — ospemifene — is a selective estrogen receptor modulator, or SERM ...

  5. Mayo researchers identify potential new treatment for subset of women with triple-negative breast cancer

    ... estrogen receptor beta. “Remarkably, we discovered that estradiol, which normally stimulates growth of cancer cells in tumors that express estrogen receptor ...

  6. Finding what works best to stop osteoporosis in its tracks

    There are numerous medications and hormone treatments used to slow or prevent bone ... selective estrogen receptor modulators, denosumab, abaloparatide ...

  7. Unlike tamoxifen, raloxifene doesn't exert estrogen-like effects on the uterus. Who it's for. Raloxifene is used to reduce the risk of invasive breast cancer if ...

  8. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    RATIONALE: Estrogen can cause the growth of breast cancer cells. ... estrogen the body makes. Everolimus may stop the ... receptor (PR) status, and negative human ...

  9. Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane with or without Chemotherapy in Treating Patients with Invasive RxPONDER Breast Cancer - Mayo Clinic

    Patients must not have received an aromatase inhibitor (AI) or a selective estrogen receptor modulator (SERM) such as tamoxifen or raloxifene within 5 years ...

  10. Letrozole After Tamoxifen in Treating Women With Breast Cancer - Mayo Clinic

    No concurrent hormone replacement therapy (e.g., megestrol); No concurrent selective estrogen-receptor modulators (e.g., raloxifene or idoxifene); Concurrent ...